Factors associated with low hepatitis B surface antigen levels in chronic hepatitis B patients treated with nucleot(s)ide analogs
The cumulative rates of achieving HBsAg levels <100 IU/mL were relatively high. Discontinuation of NA may be considered based on HBsAg and HBcrAg levels during the course of NA therapy.
Authors
- Yasuhito Tanaka (ORCID: https://orcid.org/0000-0002-2473-6966)
- Kei Fujiwara (ORCID: https://orcid.org/0000-0003-4531-4444)
- Hiromi Kataoka (ORCID: https://orcid.org/0000-0001-9491-0723)
- Hayato Kawamura (ORCID: https://orcid.org/0000-0002-7679-4279)
- Takako Inoue (ORCID: https://orcid.org/0000-0001-8801-5888)
- Kentaro Matsuura (ORCID: https://orcid.org/0009-0005-0163-3971)
- Takanori Suzuki (ORCID: https://orcid.org/0000-0002-8940-2393)
Institutions
- Nagoya City University (JP)
- Nagoya City University Hospital (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1111/hepr.14129
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Japan Agency for Medical Research and Development